Issue link: https://htpgraphics.uberflip.com/i/116750
The story so far SCENARIOS Professors Table and Kent have developed a method of using radiotherapy to target and destroy cancerous cells without destroying the healthy cells around them. A small but essential part of the equipment required to do this was developed by Tom Doyle as part of his Physics final year project, under the tutelage of Clara Kent. Brian Hodgson and Prof. Table have developed a new, effective Aromatose Inhibitor, for the treatment of breast cancer. IPP is extremely interested in its possibilities as a new drug therapy for breast cancer, as early tests have shown excellent results. IPP is keen to ensure protection of the invention from an early stage. Its marketing team has even come up with the name AROINHIB to market the drug under. Emily attends alternative therapy evening classes at North Ryedale College. She has become interested in the possible uses of alternative therapies in cancer treatment and has spent a lot of her spare time researching the subject. She even took one of her holidays in Denver, USA to attend a conference on the subject. At the conference, an academic from The Institute of Stunford presented a paper on the possible uses of plant extracts in lung cancer therapy. Since hearing that academic, Emily has become interested in the use of a South American plant extract for the treatment of breast and cervical cancers. Emily has been using Lakeland's labs, alongside doing her PhD work, to experiment with the extract which she has had shipped in from Brazil. Having heard about NWP's strategies and reputation through the grapevine, Emily wishes to approach it with her initial findings, in the hope that it might fund her further work. 6